InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（0 笔）
内部人交易记录
高级管理人员已披露买入
0
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
无可用的信号评分。
Discover the complete record of transactions filed by Giza, Helen Pring, Management Board. Officer active across 1 company, notably Fresenius Medical Care AG. In total, 2 reports have been published. Activity tracked since 16 March 2026. The latest transaction was filed on 16 March 2026 (Other). Regulator: BaFin. The full history is accessible without signup.
Companies and markets linked to Giza, Helen Pring
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报2 总计
11,397.515 股@ €39.960.0040% mcap50.0% 占其流量ShareISIN DE0005785802BAFIN:40001001
11,397.515 股@ €39.960.0040% mcap50.0% 占其流量ShareISIN DE0005785802BAFIN:40001001-2c92299809d8
2 条申报中的 2 条
About Giza, Helen Pring
Helen Pring Giza is a Management Board Member at Fresenius Medical Care AG. In this role, she oversees operations and contributes to the company's strategic development. With a strong background in the healthcare sector, Helen Pring Giza plays a key role in developing innovative solutions. Her commitment to operational excellence is essential for the success of Fresenius Medical Care.
